Watch as "Inside KU" interviews Julie Nagel about KUIC's focus on turning the university's research into industry.
Julie S. Nagel is the President of KU Innovation and Collaboration and Associate Vice Chancellor for Innovation & Entrepreneurship at the University of Kansas and the University of Kansas Medical Center. In this role, she is leading a university-wide strategy to drive entrepreneurship and commercialization of faculty technology. Dr. Nagel is leading the intellectual property, company formation, corporate outreach and foundation research relationship groups at KU. She also holds the role of Executive Director of Corporate Partnerships in KUIC where she has consolidated industrial relations and is implementing large scale programs to involve industry in translational research in areas of excellence at KU. Prior to KU, she was the Managing Director of the Oncological Sciences Center in Discovery Park at Purdue University.
Julie received a Ph.D. from the University of Tennessee, Knoxville in Environmental Toxicology where she was the recipient of an International Philanthropy Education Organization (PEO) Scholar Award, University of Tennessee Science Alliance Award for Outstanding Scholarly Achievement by a Graduate Student, and an Arthur E. Yates Graduate Fellowship. She did postdoctoral training at the Institute of Toxicology at Wayne State University. She left the University as the 13th employee of a start-up company from the University of Michigan. As Technical Coordinator, for Rubicon Genomics, Inc., she was responsible for developing a federal funding pipeline into the company. Dr. Nagel then joined Biotechnology Business Consultants, LLC in Ann Arbor, Michigan as Program Director where she successfully directed both statewide and regional programs providing assistance to Life Science entrepreneurs. She has developed and implemented numerous programs to assist early stage life science entrepreneurs including a federal grant opportunity matching program and a federal grant strategy program. At Purdue University, Julie managed the portfolio of interdisciplinary cancer projects including the Cancer Care Engineering project, an $8M multi-institutional project where she established and managed multiple clinical sites including a community hospital/practice based site. She has been instrumental in establishing partnerships and creating large projects and programs to translate technology in the academic setting.